Acute Investment Advisory’s iShares Ultra Short Duration Bond Active ETF ICSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,682
Closed -$1.65M 19
2025
Q4
$1.65M Sell
32,682
-4,089
-11% -$207K 16.01% 2
2025
Q3
$1.87M Sell
36,771
-9,215
-20% -$467K 15.68% 2
2025
Q2
$2.33M Sell
45,986
-32,823
-42% -$1.66M 19.01% 2
2025
Q1
$4M Sell
78,809
-308,039
-80% -$15.6M 20.1% 2
2024
Q4
$19.5M Sell
386,848
-334,763
-46% -$16.9M 21.41% 2
2024
Q3
$36.6M Sell
721,611
-14,302
-2% -$723K 21.03% 2
2024
Q2
$37.2M Sell
735,913
-192,256
-21% -$9.7M 21.2% 2
2024
Q1
$46.9M Buy
928,169
+38,371
+4% +$1.94M 31.46% 2
2023
Q4
$44.8M Buy
889,798
+49,258
+6% +$2.48M 26.5% 2
2023
Q3
$42.3M Buy
+840,540
New +$42.2M 25.43% 2

Other funds holding ICSH

Acute Investment Advisory's ICSH Position: Q1 2026 in Review

Acute Investment Advisory sold out of iShares Ultra Short Duration Bond Active ETF (ICSH) in Q1 2026, closing a stake of 32,682 shares — an estimated $1.65M sold.

Acute Investment Advisory first reported a position in ICSH in Q3 2023 and held it in 10 quarters. The position peaked at $46.9M in Q1 2024. 522 funds tracked by Wall St. Rank hold ICSH as of Q1 2026.

  • Acute Investment Advisory reported no remaining iShares Ultra Short Duration Bond Active ETF position as of Q1 2026 after selling out during the quarter.
  • Acute Investment Advisory sold 32,682 iShares Ultra Short Duration Bond Active ETF shares in Q1 2026, an estimated $1.65M.
  • Acute Investment Advisory first reported a position in iShares Ultra Short Duration Bond Active ETF in Q3 2023 and held it in 10 quarters.
  • Acute Investment Advisory's iShares Ultra Short Duration Bond Active ETF position peaked at $46.9M in Q1 2024.
  • 522 funds tracked by Wall St. Rank held iShares Ultra Short Duration Bond Active ETF as of Q1 2026.

Based on Acute Investment Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.